GC Ventures America
Corporate Venture Capital function for PTT Global Chemical, the biggest polyolefin manufacturer in Southeast Asia.
Dr. Tony Sun
CVC ManagerGCV Life
Life science-focused Innovation licensing organizations looking to commercialize global innovations for the Indian and South Asian markets through a unique partnership-led model.
Dr. Chirag Jain
AnalystGenome Biologics
We are leaders in therapeutic target discovery and RNA-targeted therapies in Cardiovascular Disease (CVD). Our technology platforms seamlessly integrate synergistically to accelerate development of therapies to treat illnesses where no other treatments have proven effective or ever existed.
We have developed a rich pipeline of therapeutics, including RNAi and NCE's for heart failure, cardiotoxicity, cardiac regeneration and rare cardiometabolic disease.
We have developed a rich pipeline of therapeutics, including RNAi and NCE's for heart failure, cardiotoxicity, cardiac regeneration and rare cardiometabolic disease.
Jonathan Ward
CEOGenScript
GenScript is a global biotech company (Stock Code: 1548. HK) with 4,000 employees worldwide. Founded in 2002, GenScript business encompass four major categories in synthetic biology, protein analysis and purification, biologics development and manufacturing, and cell therapy.
Ms. Hong Qian
Head of Catalog Product Unit
Mr. Paul Kao
VP, Business Development, Life Science GroupGlenpharma AB
Glenpharma AB is a small privately owned research spin-off from Pfizer-Pharmacia, formed in Sweden in 2002 to exploit novel technology patented by its founders;
We offer patented synergistic combinations of biopolymers for;
a) accelerated repair of acute tendon /ligament injuries in human applications ( such as sprained ligaments / tendons in shoulder, elbow, knee, ankle, etc , in both sports injury scenarios and in the elderly ) , or in veterinary indications (e.g. high performance horses); The product accelerates healing at least 3 times faster than the normal healing process.b) for prevention of unwanted adhesions between tissues after major thoracic, abdominal , fertility or orthopedic surgery. In studies on prevention of difficult adhesions after cardiac surgery, for example, adhesion scores were < 10% of those in control groups.
c) for effective control of acute pain in advanced joint disease (osteo-arthritis (OA); .; Clinical documentation in advanced OA indicates that onset of pain relief is much faster and of longer duration than current standards for viscosupplementation.;
Each of the above biopolymer "viscous fluid implants" are also ideal drug delivery media for treatment of ancillary complications. All component biopolymers are well documented APIs, i.e. without the toxicty and other regulatory issues generally associated with "New Chemical Entities". Glenpharma´s current patent protection covers most major international markets including USA, Europe and P R China. Glenpharma is primarily seeking Chinese partners for Licensing-out within the fields of orthopedics or major surgery.. If neccessary , we can offer contract-manufacturing options in Europe if not available in China.;
Peter Buckley
CEOGlobal Clinical Trials (GCT)
Global Clinical Trials (GCT) is a premium contract-research organization (CRO) that offers support for the clinical Phase I-IV studies as well as post-marketing activities to Big Pharma, small and medium-sized biotech enterprises, groups and funds, as well as large universities and institutions. Headquartered in Princeton, USA, GCT offers both local and global support through 10 own operational offices in Bulgaria, Czech Republic, Georgia, Hungary, India, Kazakhstan, Latvia, Lithuania, Estonia, Moldova, Poland, Romania, Russia, Slovakia, Ukraine.
GCT team, that now consists of over 100 full-time clinical research professionals, gives individualized attention to each project and provides full range of services following the latest GCP, EMA and FDA guidelines at every stage of product development path. Our monitors and project managers are all certified clinicians experienced in GCP clinical research. Our experience, competent staff, close contact with the KOLs and the immense enrollment potential of the covered region ensure fast study start-up and compliance with the set timelines.
GCT owns 400 sq.m. (4300 ft2) Drug Storage and Distribution facility in St. Petersburg, Russia. It is fully equipped, disaster protected and has multiple modes of storage (ambient, climate controlled, refrigerated, frozen). High standards of work and client satisfaction are proved by the fact that more than 80% of the business come from repeat clients.
Since 2006 GCT is also an Exclusive Partner of “The White Nights” International ophthalmology congress in Russia.
GCT team, that now consists of over 100 full-time clinical research professionals, gives individualized attention to each project and provides full range of services following the latest GCP, EMA and FDA guidelines at every stage of product development path. Our monitors and project managers are all certified clinicians experienced in GCP clinical research. Our experience, competent staff, close contact with the KOLs and the immense enrollment potential of the covered region ensure fast study start-up and compliance with the set timelines.
GCT owns 400 sq.m. (4300 ft2) Drug Storage and Distribution facility in St. Petersburg, Russia. It is fully equipped, disaster protected and has multiple modes of storage (ambient, climate controlled, refrigerated, frozen). High standards of work and client satisfaction are proved by the fact that more than 80% of the business come from repeat clients.
Since 2006 GCT is also an Exclusive Partner of “The White Nights” International ophthalmology congress in Russia.
Aleksandr Stiblo
Director, Business DevelopmentGolden State Green World
Golden State Green World LLC, is a CBG Hemp Cultivator, located in Riverside County, California. Our team has ten years of extensive greenhouse design and a diverse growing experience. We apply our grow methodologies and eco-agricultural knowledge to supply the global market with high quality, contaminant-free, organic CBG enriched hemp products. Our vision is to become a global distributor of organic CBG infused products that will provided medical and therapeutically benefits to the end user.